Topic summary
57%17 analyzed articles/videos10,820 analyzed words
BS Summary: These Fda results contain 52 faulty reasoning types, including Biased Writer Voice, Framing Effect, and Hasty Generalization, with Negativity Bias as the most egregious example at 12.7% saturation with 5,837 hits. Analysis detected 43,267 faulty-reasoning hits from 46,076 analyzed words across 17 articles, generating a BS Score of 1.8% and a BS Rank of 17% (13,238 of 15,920 topics). This Fda is better (less manipulative) than 83.20% of the peer group.

Ranking context

Position among analyzed topics

17% percentile
025507510016.8% percentile
1.8% BS Score17 analyzed articles46.1K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

TopicSitewideShared scale 0–50%
0.0%10%20%30%40%50%Framing EffectSitewide 26.9%Topic 6.7%6.7%Appeal to EmotionSitewide 15.9%Topic 4.1%4.1%Negativity BiasSitewide 19.2%Topic 12.7%12.7%In-Group BiasSitewide 6.9%Topic 0.6%0.6%Appeal to AuthoritySitewide 11.1%Topic 5.0%5.0%Availability HeuristicSitewide 9.1%Topic 3.7%3.7%Halo EffectSitewide 6.7%Topic 1.5%1.5%Optimism BiasSitewide 6.0%Topic 2.1%2.1%Overconfidence BiasSitewide 4.6%Topic 0.8%0.8%Biased Writer VoiceSitewide 5.3%Topic 8.6%8.6%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Topic 6.7%, sitewide 26.9%Negativity Bias: Topic 12.7%, sitewide 19.2%Appeal to Emotion: Topic 4.1%, sitewide 15.9%Appeal to Authority: Topic 5.0%, sitewide 11.1%Availability Heuristic: Topic 3.7%, sitewide 9.1%Biased Writer Voice: Topic 8.6%, sitewide 5.3%Hasty Generalization: Topic 6.3%, sitewide 8.1%Confirmation Bias: Topic 6.0%, sitewide 7.5%In-Group Bias: Topic 0.6%, sitewide 6.9%Halo Effect: Topic 1.5%, sitewide 6.7%Optimism Bias: Topic 2.1%, sitewide 6.0%Anecdotal: Topic 3.1%, sitewide 5.2%Overconfidence Bias: Topic 0.8%, sitewide 4.6%Anchoring Bias: Topic 0.9%, sitewide 4.0%Self-Serving Bias: Topic 2.2%, sitewide 3.7%Post Hoc (False Cause): Topic 3.1%, sitewide 3.3%Out-Group Homogeneity Bias: Topic 0.3%, sitewide 3.1%Ambiguity (Equivocation): Topic 2.8%, sitewide 0.8%Fundamental Attribution Error: Topic 1.2%, sitewide 2.7%Recency Bias: Topic 1.6%, sitewide 2.7%Loss Aversion: Topic 0.5%, sitewide 2.5%Unattributed Quote: Topic 2.3%, sitewide 1.1%Bandwagon: Topic 0.6%, sitewide 2.2%Status Quo Bias: Topic 1.2%, sitewide 2.2%Framing EffectSitewide rateTopic rate

Analyzed articles and videos

In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides77%
STAT42%By Sarah Todd0% Lizzy Lawrence81%7/23/2026, 8:08:56 PM
FDA is urged by advocacy group to ban DTC prescription drug ads59%
STAT42%By Ed Silverman61%7/23/2026, 1:00:00 PM
Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system, rebuild trust in CDC37%
CNBC55%By Angelica Peebles53%7/23/2026, 12:32:10 PM
Expect a clash at today’s FDA peptide panel32%
STAT42%By Theresa Gaffney35%7/23/2026, 11:34:25 AM
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers45%
Orlando Sentinel48%By Associated Press60%7/23/2026, 4:02:50 AM
As parasite spawned chaos, Monterey County-based Taylor Farms slow-walked its response31%
The Mercury News22%By Bloomberg74%7/22/2026, 12:42:37 PM
FDA still focused on lettuce supplier as source of parasite, despite faulty test result31%
STAT42%By Associated Press60%7/20/2026, 8:37:59 PM
FDA CBER, ACA subsidy fallout, cyclosporiasis: Morning Rounds24%
STAT42%By Theresa Gaffney35%7/15/2026, 11:58:15 AM
FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist21%
STAT42%By Matthew Chapman85% Kathryn Kranhold — The Examination25%7/14/2026, 9:30:00 AM
Halfway into the year, biotech is booming86%
STAT42%By Adam Feuerstein43%7/2/2026, 10:30:00 AM